Research Article

Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group

Table 4

Factors of residual tumor at the repeat TURBT according to univariate and multivariate logistic regression models.

UnivariateMultivariate
OR95% CIp-valueOR95% CIP value

Sex1.360.70-2.760.3811.050.47-2.390.913

BMI0.950.88-1.030.2330.980.89-1.070.625

Number of previous TURBT<0.0010.016

0ReferenceReference

110.384.00-26.95<0.0016.491.35-31.060.019

26.491.44-29.260.01511.561.45-92.100..021

Previous intravesical therapy1.220.42-4.020.7190.100.01-0.650.017

Gross hematuria1.901.07-3.360.0272.4571.245-4.8500.010

T stage (Ta/T1)0.910.49-1.740.7701.060.45-2.510.901

Tumor grade at initial TURBT (Low/High)3.051.56-6.13<0.0012.561.13-6.040.026

Concomitant CIS (yes/no)8.232.86-34.80<0.0018.062.43-37.620.002

LVI2.160.51-14.710.3412.510.50-18.910.298

Tumor multiplicity at initial TURBT0.029

1ReferenceReference

2-71.861.07-3.240.0272.061.11-3.810.021

≥83.211.26-8.140.0142.851.05-7.730.040

Tumor size at initial TURBT (<3 cm/≥3 cm)1.881.13-3.180.0161.9251.014-3.6560.045

Referred/Non-referred status3.751.96-7.68<0.0013.471.03-11.200.036

BMI: body mass index; TURBT: transurethral resection of bladder tumor; CIS: carcinoma in situ; LVI: lymphovascular invasion.